Abstract
Introduction: The majority of psychiatric patients suffer from sexual dysfunction. Although sexual
impairment is a major cause for non-compliance in psychiatric patients, it remains
underdiagnosed by the attending physician. Therefore, the aim of the following study
was to examine sexual behaviour and sexual dysfunction in a large sample of psychiatric
patients.
Methods: Male psychiatric inpatients received a questionnaire for sexuality (“Sexualitätsfragebogen
für Männer”, SFM) examining various aspects of sexual behaviour (e.g., value of sexuality,
sexual dysfunction). Questionnaires from 351 patients were analysed. Additionally,
55 male healthy controls and 52 male patients with epilepsy were recruited.
Results: Psychiatric patients demonstrated more severe sexual dysfunction in the acute phase
of their illness as well as in the premorbid time period compared with healthy controls.
Patients with epilepsy showed only mild current sexual dysfunction (in the acute phase
of the illness), with the exception of persisting erectile dysfunction. When comparing
the two groups of patients, the psychiatric patients reported more current sexual
impairments.
Discussion: Sexual dysfunction is not limited to the acute phase of psychiatric illnesses. Hence,
treatment and follow-up must be geared towards such aspects of the quality of life
while focussing on coping strategies.
References
- 1
Andersch S, Hetta J.
A 15-year follow-up study of patients with panic disorder.
Eur Psychiatry.
2003;
18
401-408
- 2
Braun M, Klotz T, Reifenrath B, Wassmer G, Engelmann U.
“KEED” First German-language validated questionnaire for assessing sexual function
[in German].
Aktuelle Urologie.
1998;
29
300-305
- 3
Cohen S, Kuhn KU, Bender S, Erfurth A, Gastpar M, Murafi A, Rothermundt M, Signerski J,
Strater B, Teusch L, Weig W, Welling A, Westheide J, Huber TJ.
Sexual impairment in psychiatric inpatients: focus on depression.
Pharmacopsychiatry.
2007;
40
58-63
- 4
Daniele A, Azzoni A, Bizzi A, Rossi A, Gainotti G, Mazza S.
Sexual behavior and hemispheric laterality of the focus in patients with temporal
lobe epilepsy.
Biol Psychiatry.
1997;
42
617-624
- 5
Duncan S, Blacklaw J, Beastall GH, Brodie MJ.
Antiepileptic drug therapy and sexual function in men with epilepsy.
Epilepsia.
1999;
40
197-204
- 6
Finn SE, Bailey JM, Schultz RT, Faber R.
Subjective utility ratings of neuroleptics in treating schizophrenia.
Psychol Med.
1990;
20
843-848
- 7
Hofer A, Rettenbacher MA, Widschwendter CG, Kemmler G, Hummer M, Fleischhacker WW.
Correlates of subjective and functional outcomes in outpatient clinic attendees with
schizophrenia and schizoaffective disorder.
Eur Arch Psychiatry Clin Neurosci.
2006;
256
246-255
- 8
Jalava M, Sillanpaa M.
Reproductive activity and offspring health of young adults with childhood-onset epilepsy:
a controlled study.
Epilepsia.
1997;
38
532-540
- 9
Karow A, Schnedler D, Naber D.
What would the patient choose? Subjective comparison of atypical and typical neuroleptics.
Pharmacopsychiatry.
2006;
39
47-51
- 10
Kelly DL, Conley RR.
A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine
on sexual functioning in people with schizophrenia.
Psychoneuroendocrinology.
2006;
31
340-346
- 11
Kennedy SH, Dickens SE, Eisfeld BS, Bagby RM.
Sexual dysfunction before antidepressant therapy in major depression.
J Affect Disord.
1999;
56
201-208
- 12
Kennedy N, Abbott R, Paykel ES.
Longitudinal syndromal and sub-syndromal symptoms after severe depression: 10-year
follow-up study.
Br J Psychiatry.
2004;
184
330-336
- 13
Lambert M, Conus P, Eide P, Mass R, Karow A, Moritz S, Golks D, Naber D.
Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic
treatment and adherence.
Eur Psychiatry.
2004;
19
415-422
- 14
MacGrath BM, Tempier RP.
Patients’ opinions of olanzapine and risperidone following long-term treatment: results
from a cross-sectional survey.
Pharmacopsychiatry.
2005;
38
147-157
- 15 Naber D. (Ed). .
Atypical neuroleptics in the treatment of schizophrenic patients [in German]. 2nd
Edition. Bremen: Uni-Med Publisher 2000
- 16
Okabe K, Mishima N.
Frequency of marital intercourse among patients with psychiatric and psychosomatic
disorders in Japan.
J Sex Marital Ther.
2004;
30
3-11
- 17
Perkins DO, Gu H, Boteva K, Lieberman JA.
Relationship between duration of untreated psychosis and outcome in first-episode
schizophrenia: a critical review and meta-analysis.
Am J Psychiatry.
2005;
162
1785-1804
- 18
Raja M, Azzoni A.
Sexual behavior and sexual problems among patients with severe chronic psychoses.
Eur Psychiatry.
2003;
18
70-76
- 19
Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A.
The international index of erectile function (IIEF): a multidimensional scale for
assessment of erectile dysfunction.
Urology.
1997;
49
822-830
- 20
Rosenberg KP, Bleiberg KL, Koscis J, Gross C.
A survey of sexual side effects among severely mentally ill patients taking psychotropic
medications: impact on compliance.
J Sex Marital Ther.
2003;
29
289-296
- 21
Smaldone M, Sukkarieh T, Reda A, Khan A.
Epilepsy and erectile dysfunction: a review.
Seizure.
2004;
13
453-459
- 22
Stahl SM.
The psychopharmacology of sex, part 2: effects of drugs and disease on the 3 phases
of human sexual response.
J Clin Psychiatry.
2001;
62
147-148
- 23
Waldinger MD, Zwinderman AH, Olivier B.
Antidepressants and ejaculation: a double-blind, randomized, fixed-dose study with
mirtazapine and paroxetine.
J Clin Psychopharmacol.
2003;
23
467-470
- 24
Wiltink J, Hauck EW, Phadayanon M, Weidner W, Beutel ME.
Validation of the German version of the International Index of Erectile Function (IIEF)
in patients with erectile dysfunction, Peyronie's disease and controls.
Int J Impot Res.
2003;
15
192-197
- 25
Westheide J, Cohen S, Bender S, Cooper-Mahkorn D, Erfurth A, Gastpar M, Huber TJ,
Maier W, Murafi A, Rothermund M, Signerski J, Sträter B, Teusch L, Weig W, Welling A,
Kühn KU.
Sexual dysfunction in psychiatric inpatients. The role of antipsychotic medication.
Pharmacopsychiatry.
40
140-145
- 26
Zajecka J.
Strategies for the treatment of antidepressant-related sexual dysfunction.
J Clin Psychiatry.
2001;
62
35-43
Correspondence
Dr. J. Westheide
Department of Psychiatry
University of Bonn
Sigmund-Freud-Str. 25
53105 Bonn
Germany
Phone: +49/228/287 156 83
Fax: +49/228/287 169 49
Email: jens.westheide@ukb.uni-bonn.de